Consolidated Statements Of Operations (USD $)	3 Months Ended				6 Months Ended				62 Months Ended
	Jun. 30, 2012		Jun. 30, 2011		Jun. 30, 2012		Jun. 30, 2011		Jun. 30, 2012
Revenue
Operating expense
General & administrative	252,168	[1],[2]	324,574	[1],[2]	483,482	[1],[2]	674,812	[1],[2]	6,556,848	[1],[2]
Total operating expense	787,782		463,768		1,310,409		1,056,505		11,176,410
Net operating loss	(787,782)		(463,768)		(1,310,409)		(1,056,505)		(11,176,410)
Other income (expense)
Interest income	213		1,111		742		1,302		77,053
Other income									244,479
Other expense	(269)		(91)		(398)		(271)		(3,934)
Total Other Income (Expense)	(56)		1,020		344		1,031		317,598
Net Loss	(787,838)		(462,748)		(1,310,065)		(1,055,474)		(10,858,812)
Loss per share
Net loss per share, basic and diluted	$ (0.01)		$ (0.01)		$ (0.02)		$ (0.02)		$ (0.24)
Basic and diluted weighted average number of common shares outstanding	58,868,713		51,649,169		58,625,066		50,524,887		44,693,637
All Other
Operating expense
Research and development	168,026	[3]	114,194	[3]	447,639	[3]	306,693	[3]	3,640,524	[3]
MD Anderson for License
Operating expense
Research and development	$ 367,588		$ 25,000		$ 379,288		$ 75,000		$ 979,038

[1] Includes $345,000 technology impairment charge for the quarter and six month periods ending 6/30/12; and $690,000 for the period from inception through 6/30/2012

[2] General & administrative expense includes stock for services, stock option and warrant expenses of $1,300 and $104,602 for the quarters ending 6/30/2012 and 6/30/2011, respectively; $3,250 and $209,378 for the six month periods ending 6/30/2012 and 6/30/2011, respectively; and $2,584,265 for the period from inception through 6/30/2012 for stock options and warrants and $318,500 in stock for services.

[3] Research and development expense includes stock option expenses of $13,411 and $16,082 for the quarters ending 6/30/2012 and 6/30/2011, respectively; $30,817 and $31,286 for the six month periods ending 6/30/2012 and 6/30/2011, respectively; and $400,171 for the period from inception through 6/30/2012